St Segment Elevation Myocardial Infarction clinical trials

Explore recruiting st segment elevation myocardial infarction clinical trials.

Recruiting st segment elevation myocardial infarction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

St Segment Elevation Myocardial Infarction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pulse Glucocorticoid Therapy In Patients With ST-Segment Elevation Myocardial Infarction (PULSE-MI)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Prehospital pulse-dose glucocorticoid in patients with STEMI – the PULSE-MI 2 trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

STunning in Acute Myocardial Infarction – Beta blockers, Angiotensin converting enzyme inhibitors and Sodium/glucose cotransporter 2 inhibitors trial (STAMI-BAS)

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

PhARMacodynamics of earlY versus Delayed Administration of TIcagrelor during CAngrelor infusion in patients with acute ST-segment elevation Myocardial Infarction: a randomized superiority study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A prospective, interventional, single-center, single-arm study to assess the effectiveness of Bempedoic acid to achieve LDL-cholesterol targets in patients following ST-elevation or Non-ST-elevation myocardial infarctions insufficiently treated with atorvastatin plus ezetimibe (HACOL-ACS)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Masked, Multicentre, Placebo-controlled, Randomized Phase IIa Clinical Trial to investigate the safety and efficacy of ApTOLL in a population of ST Elevation Myocardial Infarct (STEMI) patients.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

St Segment Elevation Myocardial Infarction trials by city

St Segment Elevation Myocardial Infarction in Toronto St Segment Elevation Myocardial Infarction in Vancouver St Segment Elevation Myocardial Infarction in Montreal St Segment Elevation Myocardial Infarction in Calgary St Segment Elevation Myocardial Infarction in Edmonton St Segment Elevation Myocardial Infarction in Ottawa St Segment Elevation Myocardial Infarction in Winnipeg St Segment Elevation Myocardial Infarction in Quebec City St Segment Elevation Myocardial Infarction in Hamilton St Segment Elevation Myocardial Infarction in Kitchener St Segment Elevation Myocardial Infarction in London St Segment Elevation Myocardial Infarction in Halifax St Segment Elevation Myocardial Infarction in New York St Segment Elevation Myocardial Infarction in Los Angeles St Segment Elevation Myocardial Infarction in Chicago St Segment Elevation Myocardial Infarction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease